NASDAQ:MBOT Microbot Medical (MBOT) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free MBOT Stock Alerts $0.87 -0.02 (-2.36%) (As of 02:49 PM ET) Add Compare Share Share Today's Range$0.87▼$0.9150-Day Range$0.87▼$1.3452-Week Range$0.86▼$4.37Volume59,256 shsAverage Volume122,516 shsMarket Capitalization$12.53 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Microbot Medical alerts: Email Address Microbot Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside682.0% Upside$7.00 Price TargetShort InterestHealthy1.77% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.60Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.08 out of 5 starsMedical Sector594th out of 907 stocksSurgical & Medical Instruments Industry67th out of 96 stocks 3.5 Analyst's Opinion Consensus RatingMicrobot Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageMicrobot Medical has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.77% of the outstanding shares of Microbot Medical have been sold short.Short Interest Ratio / Days to CoverMicrobot Medical has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Microbot Medical has recently increased by 47.37%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldMicrobot Medical does not currently pay a dividend.Dividend GrowthMicrobot Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MBOT. Previous Next 3.7 News and Social Media Coverage News SentimentMicrobot Medical has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Microbot Medical this week, compared to 1 article on an average week.Search Interest10 people have searched for MBOT on MarketBeat in the last 30 days. MarketBeat Follows4 people have added Microbot Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Microbot Medical insiders have not sold or bought any company stock.Percentage Held by Insiders10.64% of the stock of Microbot Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 16.30% of the stock of Microbot Medical is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Microbot Medical is -0.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Microbot Medical is -0.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMicrobot Medical has a P/B Ratio of 2.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About Microbot Medical Stock (NASDAQ:MBOT)Microbot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom. It primarily engages in the research, design, and development of next generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company also offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. In addition, it provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company also has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.Read More MBOT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MBOT Stock News HeadlinesApril 18, 2024 | msn.comMicrobot Medical (MBOT) Price Target Decreased by 12.50% to 7.14April 18, 2024 | americanbankingnews.comAnalysts Offer Predictions for Microbot Medical Inc.'s Q1 2024 Earnings (NASDAQ:MBOT)April 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.April 17, 2024 | americanbankingnews.comMicrobot Medical (NASDAQ:MBOT) Price Target Cut to $7.00 by Analysts at HC WainwrightApril 16, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Halozyme (HALO), Cognition Therapeutics (CGTX)April 15, 2024 | globenewswire.comMicrobot Medical Shares Status Following Recent Geopolitical EventsMarch 28, 2024 | msn.com3 AI Stocks Wall Street Expects to Return Up to 595% in 2024March 27, 2024 | investorplace.comMBOT Stock Earnings: Microbot Medical Misses EPS for Q4 2023April 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.March 16, 2024 | ca.finance.yahoo.comMBOT Apr 2024 3.000 callFebruary 26, 2024 | benzinga.comMicrobot Medical Stock (NASDAQ:MBOT) Dividends: History, Yield and DatesFebruary 21, 2024 | finance.yahoo.comMBOT Jul 2024 2.500 putFebruary 21, 2024 | finance.yahoo.comMBOT Apr 2024 5.000 callFebruary 18, 2024 | finance.yahoo.comMBOT Mar 2024 2.500 callFebruary 5, 2024 | finanznachrichten.deMicrobot Medical Inc.: Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the USFebruary 5, 2024 | msn.comMicrobot files FDA application for clinical study of Liberty systemFebruary 5, 2024 | finance.yahoo.comMicrobot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the USFebruary 2, 2024 | benzinga.comLooking Into Microbot Medical's Recent Short InterestJanuary 31, 2024 | msn.comMicrobot Medical Settles: Regulation FD Disclosure UpdateJanuary 30, 2024 | finanznachrichten.deMicrobot Medical Inc.: Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal MattersJanuary 30, 2024 | msn.comMicrobot Medical announces settlement resolving legal mattersJanuary 30, 2024 | finance.yahoo.comMicrobot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal MattersJanuary 18, 2024 | finance.yahoo.comMicrobot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical StudyDecember 29, 2023 | marketwatch.comMicrobot Medical Shares Drop 20% After Exercising Investment OptionsDecember 29, 2023 | msn.comGold Moves Lower; Microbot Medical Shares SlideDecember 29, 2023 | msn.comMicrobot Medical down 22%, exercises investment options for $2.73M proceedsDecember 29, 2023 | finance.yahoo.comMicrobot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq RulesSee More Headlines Receive MBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/27/2024Today4/25/2024Next Earnings (Estimated)5/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:MBOT CUSIPN/A CIK883975 Webwww.microbotmedical.com Phone(781) 875-3605Fax781-556-5347Employees21Year Founded2010Price Target and Rating Average Stock Price Target$7.00 High Stock Price Target$7.00 Low Stock Price Target$7.00 Potential Upside/Downside+685.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,740,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-164.13% Return on Assets-125.22% Debt Debt-to-Equity RatioN/A Current Ratio2.09 Quick Ratio2.09 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.38 per share Price / Book2.34Miscellaneous Outstanding Shares14,400,000Free Float12,867,000Market Cap$12.83 million OptionableOptionable Beta1.64 Social Links The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Harel Gadot (Age 51)Co-Founder, President, CEO & Chairman Comp: $813.82kMr. Yoseph Bornstein (Age 65)Co-Founder & Independent Director Comp: $13.12kMs. Rachel Vaknin (Age 44)Chief Financial Officer Comp: $212.97kDr. Simon Sharon MBA (Age 63)MSc, CTO & GM of Microbot Israel Comp: $381.51kDr. Juan Diaz-Cartelle (Age 48)Chief Medical Officer Key CompetitorsBiotricityNASDAQ:BTCYNEXGELNASDAQ:NXGLPetVivoNASDAQ:PETVT2 BiosystemsNASDAQ:TTOONeuroMetrixNASDAQ:NUROView All CompetitorsInstitutional OwnershipArmistice Capital LLCBought 300,000 shares on 2/13/2024Ownership: 2.562%View All Institutional Transactions MBOT Stock Analysis - Frequently Asked Questions Should I buy or sell Microbot Medical stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MBOT shares. View MBOT analyst ratings or view top-rated stocks. What is Microbot Medical's stock price target for 2024? 1 equities research analysts have issued 12 month target prices for Microbot Medical's stock. Their MBOT share price targets range from $7.00 to $7.00. On average, they anticipate the company's share price to reach $7.00 in the next twelve months. This suggests a possible upside of 682.0% from the stock's current price. View analysts price targets for MBOT or view top-rated stocks among Wall Street analysts. How have MBOT shares performed in 2024? Microbot Medical's stock was trading at $1.64 on January 1st, 2024. Since then, MBOT stock has decreased by 45.4% and is now trading at $0.8951. View the best growth stocks for 2024 here. Are investors shorting Microbot Medical? Microbot Medical saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 255,400 shares, an increase of 47.4% from the March 31st total of 173,300 shares. Based on an average trading volume of 100,400 shares, the short-interest ratio is presently 2.5 days. View Microbot Medical's Short Interest. When is Microbot Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 15th 2024. View our MBOT earnings forecast. How were Microbot Medical's earnings last quarter? Microbot Medical Inc. (NASDAQ:MBOT) released its quarterly earnings results on Wednesday, March, 27th. The biotechnology company reported ($0.26) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.01. When did Microbot Medical's stock split? Shares of Microbot Medical reverse split on the morning of Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. What other stocks do shareholders of Microbot Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include Advanced Micro Devices (AMD), Athersys (ATHX), NVIDIA (NVDA), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Novavax (NVAX), Pfizer (PFE), Micron Technology (MU) and Sorrento Therapeutics (SRNE). How do I buy shares of Microbot Medical? Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MBOT) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
